SR-3029
SR-3029 is a potent and ATP competitive CK1δ and CK1ε inhibitor, with IC50s of 44 nM and 260 nM, respectively, and Kis of 97 nM for both kinases.
Product Specifications
CAS Number
1454585-06-8
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Casein Kinase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/SR-3029.html
Purity
99.73
Solubility
DMSO : ≥ 30 mg/mL
Smiles
FC1=CC(N2C=NC3=C(NCC4=NC5=CC=C(F)C(F)=C5N4)N=C(N6CCOCC6)N=C23)=CC=C1
Molecular Formula
C23H19F3N8O
Molecular Weight
480.45
Precautions
H315, H319, H335
References & Citations
[1]Bibian M, et al. Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties. Bioorg Med Chem Lett. 2013 Aug 1;23 (15) :4374-80.|[2]Rosenberg LH, et al. Therapeutic targeting of casein kinase 1δ in breast cancer. Sci Transl Med. 2015 Dec 16;7 (318) :318ra202.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CK1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740845-100 1x 100 µL
Mucin 1 / EMA / Episialin / CD227 (MUC1/845), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402698-100 1x 100 µL
PMEPA1 / TMEPAI (Tumor Suppressor Oncoprotein) (PMEPA1/2698), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
